Global Rosuvastatin Calcium Market Growth 2023-2029

Global Rosuvastatin Calcium Market Growth 2023-2029

Rosuvastatin calcium (CAS 147098-20-2, molecular formula being C44H54CaF2N6O12S2) is the active pharmaceutical ingredient for the once-a-day dyslipidaemia treatment Crestor, it is one approved API which can be used to reduce the risk of heart attack and stroke.Rosuvastatin calcium is a hygroscopic powder suitable for the manufacture of tablets and capsules. The appropriate excipients need to be added. The particle size of the product is designed in such a way that optimal dissolution can be obtained (depending on formulation).
Rosuvastatin Calcium is a member of the drug class of statins, used in combination with exercise, diet, and weight-loss to treat high cholesterol and related conditions, and to prevent cardiovascular disease. It works by slowing the production of cholesterol in the body to decrease the amount of cholesterol that may build up on the walls of the arteries and block blood flow to the heart, brain, and other parts of the body. Rosuvastatin Calcium was developed by Shionogi and has been formulated into finished oral dosage form and marketedby AstraZeneca as Crestor, Abbott Laboratories as R2.
LPI (LP Information)' newest research report, the “Rosuvastatin Calcium Industry Forecast” looks at past sales and reviews total world Rosuvastatin Calcium sales in 2022, providing a comprehensive analysis by region and market sector of projected Rosuvastatin Calcium sales for 2023 through 2029. With Rosuvastatin Calcium sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Rosuvastatin Calcium industry.
This Insight Report provides a comprehensive analysis of the global Rosuvastatin Calcium landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Rosuvastatin Calcium portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Rosuvastatin Calcium market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Rosuvastatin Calcium and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Rosuvastatin Calcium.
The global Rosuvastatin Calcium market size is projected to grow from US$ 514.3 million in 2022 to US$ 683.6 million in 2029; it is expected to grow at a CAGR of 683.6 from 2023 to 2029.
In additional, EU is also the largest consumer of rosuvastatin calcium, about 34% of the global production was consumed in EU. China is the second producer with the market share of 28%. Top Three manufacturers in rosuvastatin calcium are AstraZeneca, MSN Laboratories, Changzhou Pharmaceutical Factory, according for 55% of the total amount.
This report presents a comprehensive overview, market shares, and growth opportunities of Rosuvastatin Calcium market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Purity 98.0%
Purity 99.0%
Other
Segmentation by application
Tablet (including dispersible tablet and general tablet)
Capsule
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
AstraZeneca
Teva Pharmaceutical Industries
MSN Laboratories
Cadila Pharmaceuticals
LGM Pharma
Bal Pharma
Changzhou Pharmaceutical Factory
Jingxin Pharm
Zhejiang Hisun Pharmaceutical
HEC Pharm
Lunan Pharmaceutical
Nanjing Frochem Tech
Lianyungang Runzhong Pharmaceutical
Shandong Bechem Chemicals
CTX Life Sciences
Key Questions Addressed in this Report
What is the 10-year outlook for the global Rosuvastatin Calcium market?
What factors are driving Rosuvastatin Calcium market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Rosuvastatin Calcium market opportunities vary by end market size?
How does Rosuvastatin Calcium break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.